Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiping He

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Oncotarget|October 28, 2015
Prevalence of deleterious ATM germline mutations in gastric cancer patientsDong-Sheng Huang, Hou-Quan Tao, Xu-Jun He, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2005
Detection and quantification of mutations in the plasma of patients with colorectal tumorsFrank Diehl, Meng Li, Devin Dressman, et al.
International Immunology|November 6, 2007
Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signalsAlison M Michie, Angela C Chan, Maria Ciofani, et al.
Communications Biology|January 3, 2024
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survivalJ Spencer Hauck, David Moon, Xue Jiang, et al.
Familial Cancer|November 28, 2018
Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndromeShahid Mahmood Baig, Ambrin Fatima, Muhammad Tariq, et al.
Neuro-Oncology|January 23, 2023
Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cellsHeng Liu, Cheng Xu, Bill H Diplas, et al.
Neuro-Oncology|October 23, 2018
Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomasBill H Diplas, Heng Liu, Rui Yang, et al.
Microbiology Spectrum|August 20, 2024
Genomic and pathogenicity analysis of two novel highly pathogenic recombinant NADC30-like PRRSV strains in China, in 2023Hao Chang, Xiaopeng Gao, Yu Wu, et al.
Oncotarget|October 22, 2013
The genetic landscape of anaplastic astrocytomaPatrick J Killela, Christopher J Pirozzi, Zachary J Reitman, et al.
Cancer Research|December 4, 2012
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomasGenglin Jin, Zachary J Reitman, Christopher G Duncan, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Oncotarget|October 28, 2015
Prevalence of deleterious ATM germline mutations in gastric cancer patientsDong-Sheng Huang, Hou-Quan Tao, Xu-Jun He, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2005
Detection and quantification of mutations in the plasma of patients with colorectal tumorsFrank Diehl, Meng Li, Devin Dressman, et al.
International Immunology|November 6, 2007
Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signalsAlison M Michie, Angela C Chan, Maria Ciofani, et al.
Communications Biology|January 3, 2024
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survivalJ Spencer Hauck, David Moon, Xue Jiang, et al.
Familial Cancer|November 28, 2018
Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndromeShahid Mahmood Baig, Ambrin Fatima, Muhammad Tariq, et al.
Neuro-Oncology|January 23, 2023
Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cellsHeng Liu, Cheng Xu, Bill H Diplas, et al.
Neuro-Oncology|October 23, 2018
Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomasBill H Diplas, Heng Liu, Rui Yang, et al.
Microbiology Spectrum|August 20, 2024
Genomic and pathogenicity analysis of two novel highly pathogenic recombinant NADC30-like PRRSV strains in China, in 2023Hao Chang, Xiaopeng Gao, Yu Wu, et al.
Oncotarget|October 22, 2013
The genetic landscape of anaplastic astrocytomaPatrick J Killela, Christopher J Pirozzi, Zachary J Reitman, et al.
Cancer Research|December 4, 2012
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomasGenglin Jin, Zachary J Reitman, Christopher G Duncan, et al.
Pageof 15